Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.62M Buy
3,851
+290
+8% +$116K 0.4% 47
2026
Q2
$1.29M Buy
3,561
+302
+9% +$103K 0.33% 65
2026
Q1
$1.15M Buy
3,259
+1,183
+57% +$422K 0.35% 56
2025
Q4
$679K Buy
+2,076
New +$659K 0.2% 99

Other funds holding AMGN

Focused Alpha's AMGN Position: Q3 2026 in Review

Focused Alpha increased its Amgen (AMGN) stake by 8.1% in Q3 2026, buying an estimated $116K and bringing the position to 3,851 shares worth $1.62M. The position accounts for 0.4% of the portfolio, ranked #47.

Focused Alpha first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Focused Alpha held 3,851 shares of Amgen worth $1.62M as of Q3 2026.
  • Focused Alpha bought 290 Amgen shares in Q3 2026, an estimated $116K.
  • Amgen made up 0.4% of Focused Alpha's portfolio in Q3 2026, its #47 holding.
  • Focused Alpha first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
  • 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.